Adam M. Brickman

Plasma pTau217 and recall test refine prognosis in Down syndrome

Using Alzheimer Biomarker Consortium-Down Syndrome data, researchers found combining plasma pTau217 with a cued recall task identifies cognitively…Using Alzheimer Biomarker Consortium-Down Syndrome data, researchers found combining plasma pTau217 with a cued recall task identifies cognitively stable adults facing clinical impairment within seven years.